Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
Jul 29, 2024

$KAR and $CAMT Drive Inspection Sector Surge with a Remarkable Weekly Performance Boost

Robots for this industry :
Swing Trader: Sector Rotation Strategy (TA&FA)
Swing Trader: Hi-tech, Consumer and Financial Sectors (Diversified) 

In recent times, inspection companies have taken center stage, experiencing a remarkable 8.87% surge in performance over the past week. Two notable players in this theme, KAR and CAMT, are particularly driving this positive momentum.

Positive Outlook Supported by Technical Indicators:

A Positive Outlook prevails in the inspection industry, as indicated by the MA50MA10 Indicator. Tickeron's optimistic stance on this group aligns with their prediction of a further 4.00% increase within the next month, with a 54% likelihood. The daily ratio of advancing to declining volumes over the last month has been encouraging at 1.04 to 1, reflecting a robust market sentiment.

Technical Analysis Insights:

  1. KAR's RSI Indicator Signals Upside Potential:

    • KAR's RSI Oscillator exited oversold territory on October 31, 2023, indicating a potential shift from a downward to an upward trend.
    • Historical analysis by A.I.dvisor reveals that in 88% of 33 similar instances, the stock moved higher after leaving oversold territory.
    • Current price movements suggest a trading range between $21.59 resistance and $14.38 support lines.
  2. CAMT Riding the Bullish Wave:

    • On November 13, 2023, CAMT's 10-day Moving Average crossed above the 50-day moving average, signaling a bullish trend.
    • Historical data indicates that in 90% of past instances when this crossover occurred, the stock continued to move higher over the following month.
    • CAMT's current price of $65.20 is comfortably above the highest resistance line at $29.66.

Market Capitalization Overview:

The average market capitalization for inspection companies stands at 2.2 billion dollars, with individual tickers ranging from 1.6 billion to 2.9 billion. Notably, CAMT holds the highest valuation in this group at 2.9 billion, while KAR is valued at the lower end with a market cap of 1.6 billion.

Highs and Lows in Price Movements:

The inspection theme has witnessed a robust average weekly price growth of 8.87%, with a monthly growth rate of 5.44%. The quarterly average price growth is an impressive 62.7%. While CAMT experienced a notable 17.88% price increase, KAR faced a marginal -0.14% decline. Recent standout performance includes OPENLANE (KAR, $14.72), which posted a remarkable +12.11% jump on 11/4/23.

Volume Analysis:

The inspection theme has seen an average weekly volume growth of 60.05%, with monthly and quarterly averages at -7.07% and 91.19%, respectively. Notable volume spikes include a record-breaking daily growth of 228% for OPENLANE on 10/11/23 and a 293% increase for Camtek on 8/25/23.

Summary:

In summary, the inspection industry is currently riding a wave of positive momentum, with KAR and CAMT standing out as key players. Technical indicators, market capitalization, and price movements all point towards a favorable outlook. Investors may find potential opportunities in these stocks, considering the historical performance and the positive sentiment prevailing in the inspection sector. As always, individual research and risk assessment are crucial before making investment decisions in the dynamic world of the stock market.


Contributor

Dem Sem's AvatarDem Sem|Expert

Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
$KAR and $CAMT Drive Inspection Sector Surge with a Remarkable Weekly Performance Boost